Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 111 Pages
Report ld: 6469179
Request Sample
Customized Report
Cell Saver Market Size(US$)

CAGR 2026-2032
3.5%
Market Size,2032
USD 351
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Cell Saver market was valued at US$ 277 million in 2025 and is anticipated to reach US$ 351 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cell Saver competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. A blood salvage machine, also known as an autologous transfusion salvage system or an autologous blood transfusion machine, is a medical device used to salvage and process a patient"s own blood during surgery before returning it to the patient. Such a system could be used to reduce the need for exogenous blood transfusions during surgery, thereby reducing the risks and complications associated with blood transfusions for patients. The blood salvage machine works by collecting the blood produced in the patient"s body through a specialized system, processing it to remove impurities and platelet aggregation, and then returning the processed blood to the patient. This method is actually a form of autologous blood transfusion, because the blood returned comes from the patient itself, and there is no compatibility problem between the donor and the recipient.
This report delivers a comprehensive overview of the global Cell Saver market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell Saver. The Cell Saver market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cell Saver market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cell Saver manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Cell Saver manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Cell Saver sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Cell Saver Market Overview
1.1 Product Definition
1.2 Cell Saver by Type
1.2.1 Global Cell Saver Market Value by Type: 2025 vs 2032
1.2.2 Intraoperative Autotransfusion Systems
1.2.3 Postoperative Autotransfusion Systems
1.2.4 Dual-Mode Autotransfusion Systems
1.3 Cell Saver by Application
1.3.1 Global Cell Saver Market Value by Application: 2025 vs 2032
1.3.2 Cardiac Surgeries
1.3.3 Orthopedic Surgeries
1.3.4 Organ Transplantation
1.3.5 Others
1.4 Global Cell Saver Market Size Estimates and Forecasts
1.4.1 Global Cell Saver Revenue 2021–2032
1.4.2 Global Cell Saver Sales 2021–2032
1.4.3 Global Cell Saver Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Cell Saver Market Competition by Manufacturers
2.1 Global Cell Saver Sales Market Share by Manufacturers (2021–2026)
2.2 Global Cell Saver Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Cell Saver Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Cell Saver, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Cell Saver, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Cell Saver, Product Types and Applications
2.7 Global Key Manufacturers of Cell Saver, Date of Entry into the Industry
2.8 Global Cell Saver Market Competitive Situation and Trends
2.8.1 Global Cell Saver Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Cell Saver Players Market Share by Revenue
2.8.3 Global Cell Saver Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cell Saver Market Scenario by Region
3.1 Global Cell Saver Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Cell Saver Sales by Region: 2021–2032
3.2.1 Global Cell Saver Sales by Region: 2021–2026
3.2.2 Global Cell Saver Sales by Region: 2027–2032
3.3 Global Cell Saver Revenue by Region: 2021–2032
3.3.1 Global Cell Saver Revenue by Region: 2021–2026
3.3.2 Global Cell Saver Revenue by Region: 2027–2032
3.4 North America Cell Saver Market Facts & Figures by Country
3.4.1 North America Cell Saver Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Cell Saver Sales by Country (2021–2032)
3.4.3 North America Cell Saver Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cell Saver Market Facts & Figures by Country
3.5.1 Europe Cell Saver Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Cell Saver Sales by Country (2021–2032)
3.5.3 Europe Cell Saver Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cell Saver Market Facts & Figures by Region
3.6.1 Asia Pacific Cell Saver Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Cell Saver Sales by Region (2021–2032)
3.6.3 Asia Pacific Cell Saver Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cell Saver Market Facts & Figures by Country
3.7.1 Latin America Cell Saver Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Cell Saver Sales by Country (2021–2032)
3.7.3 Latin America Cell Saver Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cell Saver Market Facts & Figures by Country
3.8.1 Middle East and Africa Cell Saver Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Cell Saver Sales by Country (2021–2032)
3.8.3 Middle East and Africa Cell Saver Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cell Saver Sales by Type (2021–2032)
4.1.1 Global Cell Saver Sales by Type (2021–2026)
4.1.2 Global Cell Saver Sales by Type (2027–2032)
4.1.3 Global Cell Saver Sales Market Share by Type (2021–2032)
4.2 Global Cell Saver Revenue by Type (2021–2032)
4.2.1 Global Cell Saver Revenue by Type (2021–2026)
4.2.2 Global Cell Saver Revenue by Type (2027–2032)
4.2.3 Global Cell Saver Revenue Market Share by Type (2021–2032)
4.3 Global Cell Saver Price by Type (2021–2032)
5 Segment by Application
5.1 Global Cell Saver Sales by Application (2021–2032)
5.1.1 Global Cell Saver Sales by Application (2021–2026)
5.1.2 Global Cell Saver Sales by Application (2027–2032)
5.1.3 Global Cell Saver Sales Market Share by Application (2021–2032)
5.2 Global Cell Saver Revenue by Application (2021–2032)
5.2.1 Global Cell Saver Revenue by Application (2021–2026)
5.2.2 Global Cell Saver Revenue by Application (2027–2032)
5.2.3 Global Cell Saver Revenue Market Share by Application (2021–2032)
5.3 Global Cell Saver Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Haemonetics
6.1.1 Haemonetics Company Information
6.1.2 Haemonetics Description and Business Overview
6.1.3 Haemonetics Cell Saver Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Haemonetics Cell Saver Product Portfolio
6.1.5 Haemonetics Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Cell Saver Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Medtronic Cell Saver Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 LivaNova
6.3.1 LivaNova Company Information
6.3.2 LivaNova Description and Business Overview
6.3.3 LivaNova Cell Saver Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 LivaNova Cell Saver Product Portfolio
6.3.5 LivaNova Recent Developments/Updates
6.4 BD
6.4.1 BD Company Information
6.4.2 BD Description and Business Overview
6.4.3 BD Cell Saver Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BD Cell Saver Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Fresenius Kabi
6.5.1 Fresenius Kabi Company Information
6.5.2 Fresenius Kabi Description and Business Overview
6.5.3 Fresenius Kabi Cell Saver Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fresenius Kabi Cell Saver Product Portfolio
6.5.5 Fresenius Kabi Recent Developments/Updates
6.6 Beijing ZKSK Technology
6.6.1 Beijing ZKSK Technology Company Information
6.6.2 Beijing ZKSK Technology Description and Business Overview
6.6.3 Beijing ZKSK Technology Cell Saver Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Beijing ZKSK Technology Cell Saver Product Portfolio
6.6.5 Beijing ZKSK Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cell Saver Industry Chain Analysis
7.2 Cell Saver Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cell Saver Production Mode & Process Analysis
7.4 Cell Saver Sales and Marketing
7.4.1 Cell Saver Sales Channels
7.4.2 Cell Saver Distributors
7.5 Cell Saver Customer Analysis
8 Cell Saver Market Dynamics
8.1 Cell Saver Industry Trends
8.2 Cell Saver Market Drivers
8.3 Cell Saver Market Challenges
8.4 Cell Saver Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Cell Saver was estimated to be worth US$ 277 million in 2025 and is projected to reach US$ 351 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 133
USD 3950.00
(Single User License)
The global Cell Saver market size was US$ 268 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
The global Cell Saver market is projected to grow from US$ 268 million in 2024 to US$ 340 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 144
USD 4900.00
(Single User License)
The global market for Cell Saver was valued at US$ 268 million in the year 2024 and is projected to reach a revised size of US$ 340 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published Date: 2025-01-16
Pages: 79
USD 2900.00
(Single User License)
The global market for Cell Saver was estimated to be worth US$ 268 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 106
USD 3950.00
(Single User License)
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published Date: 2024-04-12
Pages: 95
USD 4900.00
(Single User License)
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published Date: 2024-01-17
Pages: 80
USD 2900.00
(Single User License)
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published Date: 2024-01-10
Pages: 100
USD 3950.00
(Single User License)
The global market for Cell Saver was estimated to be worth US$ 277 million in 2025 and is projected to reach US$ 351 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-06-16
Pages: 133
The global Cell Saver market size was US$ 268 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
The global Cell Saver market is projected to grow from US$ 268 million in 2024 to US$ 340 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 144
The global market for Cell Saver was valued at US$ 268 million in the year 2024 and is projected to reach a revised size of US$ 340 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published: 2025-01-16
Pages: 79
The global market for Cell Saver was estimated to be worth US$ 268 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 106
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published: 2024-04-12
Pages: 95
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published: 2024-01-17
Pages: 80
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published: 2024-01-10
Pages: 100
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now